Sponsors

Whooping cough, the resurgence of a vaccine preventable disease

Dr Neil Bentley looks at the history, causes and treatment of whooping cough, as well as examining the vaccine issues which may have contributed to a recent resurgence of the condition in many countries around the world.

Pertussis disease, otherwise referred to as whooping cough or the ‘100-day cough’ is caused by members of the Bordetella spp. There are currently 16 members of the species and 12 that have been known to cause human infection: B. pertussis, B. parapertussis, B. bronchiseptica, B. avium, B. hinzii, B. holmesii, B. trematum, B. ansorpii, B. petrii, B. broncialis, B. flabilis, and
B. sputigena. Of these, B. pertussis and B. parapertussis are known to be the causative organisms of whooping cough, with the latter causing a milder form of the disease.1 These bacteria are small aerobic Gram-negative coccobacilli usually seen singularly or in pairs on Gram staining.2 They are transmitted via airborne droplets, are highly contagious and considered more transmissible than SARS-CoV-2.3 Incubation periods are usually around 7-10 days but can be as much as 20 days, and the patient remains infectious for up to five weeks.1 Diagnosis is often difficult as pertussis disease is initially not unlike common viral upper respiratory tract infections (URT) and sometimes can present atypically.4 Moreover, the organism is fastidious, slow growing and requires specialist selective media.2 Bordetella spp. are hazard group 2 organisms;5 however, with clinical samples coming from the lower respiratory tract Mycobacterium tuberculosis, a hazard group 3 organism needs to be considered. 

History

There have been a number of different names associated with pertussis disease including those from the Anglo-Saxon word ‘hwostana’ meaning cough,6 through ‘chincough’,7 to the commonly used term whooping cough4 and more recently to 100-day cough as frequently used by the press.8

Log in or register FREE to read the rest

This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text. If you don't already have an account, please register with us completely free of charge.

Latest Issues

The British Association for Cytopathology Annual Scientific Meeting

Aztec Hotel and Spa, Bristol, BS32 4TS
18 October, 2024

UK NEQAS: Navigating Quality Standards in Point of Care Testing

The Hyatt Regency Hotel, Birmingham, UK
23 October, 2024

Pathology Visions 24

Hyatt Regency, Orlando, FL
3-5 November, 2025

Medica

Messe Dusseldorf
11-14 November, 2024

POCT-for-Scot: Bringing the future to you

SEC Arena, Glasgow
14 November, 2024